주요학력

  2007.03-2011.02 부산대학교 (공학사, 이학사- 정보컴퓨터공학 및 의생명과학)

  2011.02-2016.08 서울대학교 (이학박사, 단백질생화학)

주요경력

  2016.09-2018.01 녹십자-목암생명과학연구소 (연구원, 희귀질환팀)

  2018.03-2023.02 Harvard Medical School & Mass General Hospital(Postdoctoral Associate)

  2023.03-2025.08 계명대학교 의과대학 해부학교실 (조교수)

  2025.09- Now       부산대학교 분자생물학과 (조교수)

주요연구분야

  Cancer Biology

  Cancer Immunology 

  Chronic inflammation

  T cell and Regulatory T cell

  Organ and Disease Histology

수상경력

  2025 사야 Medical Prize (사야재단)

  2020 Scientific Discovery Award (Irving Family Foundation-Cancer immunology)

  2019 KASBP-SAMSUNG Biologics Fellowship Award

  2019 박사후국외연수 (한국연구재단)

학회활동

  한국분자세포생물학회 단백질대사분과 운영위원

  한국분자세포생물학회 암미세환경분과 운영위원

  통합생물학회 운영위원

  대한해부학회 운영위원

주요연구업적

1. Huang M^#, Wang D^#, Huang J, Bae AN, Xia Y, Zhao X, Mortaja M, Azin M, Collier M R, Semenov Y R, Mino-Kenudson M, Park JH* and Demehri S* (2025) Hepatitis B virus promotes liver cancer by modulating the immune response to environmental carcinogens. Nat. Commun. 2025 Jun 27;16(1):5360. *Corresponding author

2. Bae AN, Mortaja M, Yeung Y P, Park JH* and Demehri S* (2025) Tropisetron suppresses chronic pancreatitis and pancreatic cancer by blocking interleukin 33 expression. Cancers. 2025 Jun 22;17(13), 2087. *Corresponding author

3. Moon SW, Lee JC, Lee JH, Kim TY and Park JH* (2025) Clinical and prognostic value of VHL in Korean patients with Rectal cancer. Medicina. 2025 Feb 10;61(2):306. *Corresponding author

4. Bae AN, Lee H, Yang H, Mukherjee S, Im SS, Lee JH and Park JH* (2025) Enhancing regulatory T cell function via mevalonate pathway inhibition prevents liver fibrosis. BBRC. 2025 Jan:742:151094. *Corresponding author

5. Lee H, Bae AN, Yang H, Lee JH and Park JH* (2024) Modulation of PRC1 promotes anticancer effects in pancreatic cancer. Cancers. 2024 Sep 27;16(19):3310. *Corresponding author

6. Park JH, Mortaja M, Son H G, Zhao X, Sloat M L, Azin M, Wang J, Collier M R, Tummala K S, Mandinova A, Bardeesy N, Semenov Y R, Mino-Kenudson M and Demehri S (2024) Statin prevents cancer development in chronic inflammation by blocking IL-33 expression. Nat. Commun. 2024 May 30;15(1):4099.

7. Park JH, Mortaja M, Azin M, Nazarian RM and Demehri S (2023) Nuclear IL-33 in fibroblasts promotes skin fibrosis. J Invest Dermatol. 2023 Jul;143(7):1302-1306.e4

8. Cheon SY^#, Park JH^#, Ameri AH, Lee RT, Nazarian RM and Demehri S (2022) IL-33/regulatory T-cell axis suppresses skin fibrosis. J Invest Dermatol. 2022 Oct 1;142(10):2668-2676. ^#Co-first Author

9.  Park JH, Ameri AH, Dempsey KE, Conrad DN, Kem M, Mino-Kenudson M and Demehri S (2021) Nuclear IL-33/SMAD signaling axis promotes cancer development in chronic inflammation. EMBO J. 2021 Apr 1:40(7):e106151.

2007.03-2011.02 부산대학교 (공학사, 이학사- 정보컴퓨터공학 및 의생명과학)

2011.02-2016.08 서울대학교 (이학박사, 단백질생화학)

2016.09-2018.01 녹십자-목암생명과학연구소 (연구원, 희귀질환팀)

2018.03-2023.02 Harvard Medical School & Mass General Hospital(Postdoctoral Associate)

2023.03-2025.08 계명대학교 의과대학 해부학교실 (조교수)

2025.09- Now 부산대학교 분자생물학과 (조교수)

2025 사야 Medical Prize (사야재단)

2020 Scientific Discovery Award (Irving Family Foundation-Cancer immunology)

2019 KASBP-SAMSUNG Biologics Fellowship Award

2019 박사후국외연수 (한국연구재단)

한국분자세포생물학회 단백질대사분과 운영위원

한국분자세포생물학회 암미세환경분과 운영위원

통합생물학회 운영위원

대한해부학회 운영위원

1. Huang M#, Wang D#, Huang J, Bae AN, Xia Y, Zhao X, Mortaja M, Azin M, Collier M R, Semenov Y R, Mino-Kenudson M, Park JH* and Demehri S* (2025) Hepatitis B virus promotes liver cancer by modulating the immune response to environmental carcinogens. Nat. Commun. 2025 Jun 27;16(1):5360. *Corresponding author

2. Bae AN, Mortaja M, Yeung Y P, Park JH* and Demehri S* (2025) Tropisetron suppresses chronic pancreatitis and pancreatic cancer by blocking interleukin 33 expression. Cancers. 2025 Jun 22;17(13), 2087. *Corresponding author

3. Moon SW, Lee JC, Lee JH, Kim TY and Park JH* (2025) Clinical and prognostic value of VHL in Korean patients with Rectal cancer. Medicina. 2025 Feb 10;61(2):306. *Corresponding author

4. Bae AN, Lee H, Yang H, Mukherjee S, Im SS, Lee JH and Park JH* (2025) Enhancing regulatory T cell function via mevalonate pathway inhibition prevents liver fibrosis. BBRC. 2025 Jan:742:151094. *Corresponding author

5. Lee H, Bae AN, Yang H, Lee JH and Park JH* (2024) Modulation of PRC1 promotes anticancer effects in pancreatic cancer. Cancers. 2024 Sep 27;16(19):3310. *Corresponding author

6. Park JH, Mortaja M, Son H G, Zhao X, Sloat M L, Azin M, Wang J, Collier M R, Tummala K S, Mandinova A, Bardeesy N, Semenov Y R, Mino-Kenudson M and Demehri S (2024) Statin prevents cancer development in chronic inflammation by blocking IL-33 expression. Nat. Commun. 2024 May 30;15(1):4099.

7. Park JH, Mortaja M, Azin M, Nazarian RM and Demehri S (2023) Nuclear IL-33 in fibroblasts promotes skin fibrosis. J Invest Dermatol. 2023 Jul;143(7):1302-1306.e4

8. Cheon SY#, Park JH#, Ameri AH, Lee RT, Nazarian RM and Demehri S (2022) IL-33/regulatory T-cell axis suppresses skin fibrosis. J Invest Dermatol. 2022 Oct 1;142(10):2668-2676. #Co-first Author

9. Park JH, Ameri AH, Dempsey KE, Conrad DN, Kem M, Mino-Kenudson M and Demehri S (2021) Nuclear IL-33/SMAD signaling axis promotes cancer development in chronic inflammation. EMBO J. 2021 Apr 1:40(7):e106151.